(Adds Outlook)
For the full year, Pharming Group N.V. (PHAR) expects revenue of $280 million to $295 million, a 14 percent to 20 percent growth. Pharming reported Loss for fourth quarter that decreased from the same period last year
The company's bottom line came in at -$2.7 million, or -$0.004 per share. This compares with -$14.6 million, or -$0.022 per share, in last year's fourth quarter.
The company's revenue for the quarter rose 48.7% to $81.2 million from $54.6 million last year.
Pharming Group N.V. earnings at a glance (GAAP) :
-Earnings (Q4): -$2.7 Mln. vs. -$14.6 Mln. last year.-EPS (Q4): -$0.004 vs. -$0.022 last year.-Revenue (Q4): $81.2 Mln vs. $54.6 Mln last year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.